EGFR and squamous cell lung carcinoma: In addition to BMP7, a separate study also found that activation of the BMP2/4-BMPR signaling pathway conferred resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with lung squamous cell carcinoma harboring mutations in the EGFR gene (19).